Remdesivir prevents MERS coronavirus disease in monkeys
- Details
- Category: Research
The experimental antiviral remdesivir successfully prevented disease in rhesus macaques infected with Middle East respiratory syndrome coronavirus (MERS-CoV), according to a new study from National Institutes of Health scientists. Remdesivir prevented disease when administered before infection and improved the condition of macaques when given after the animals already were infected.
Scientists find ally in fight against brain tumors: Ebola
- Details
- Category: Research
Glioblastomas are relentless, hard-to-treat, and often lethal brain tumors. Yale scientists have enlisted a most unlikely ally in efforts to treat this form of cancer - elements of the Ebola virus.
"The irony is that one of the world's deadliest viruses may be useful in treating one of the deadliest of brain cancers," said Yale's Anthony van den Pol, professor of neurosurgery, who describes the Yale efforts Feb. 12 in the Journal of Virology.
Personalized cancer vaccines
- Details
- Category: Research
Therapeutic cancer vaccines were first developed 100 years ago and have remained broadly ineffective to date. Before tangible results can be achieved, two major obstacles must be overcome. Firstly, since tumor mutations are unique to each patient, cancer cell antigens must be targeted extremely precisely, which is very hard to achieve.
Coronavirus outbreak raises question: Why are bat viruses so deadly?
- Details
- Category: Research
It's no coincidence that some of the worst viral disease outbreaks in recent years - SARS, MERS, Ebola, Marburg and likely the newly arrived 2019-nCoV virus - originated in bats. A new University of California, Berkeley, study finds that bats' fierce immune response to viruses could drive viruses to replicate faster, so that when they jump to mammals with average immune systems, such as humans, the viruses wreak deadly havoc.
Botanical drug is shown to help patients with head and neck cancers
- Details
- Category: Research
In a UCLA-led phase I clinical trial, a new plant-based drug called APG-157 showed signs of helping patients fight oral and oropharyngeal cancers. These cancers are located in the head and the neck. APG-157 is made up of multiple compounds produced by plants, including curcumin. UCLA Jonsson Comprehensive Cancer Center researchers found that treatment with this botanical drug resulted in
Portable lab you plug into your phone can diagnose illnesses like coronavirus
- Details
- Category: Research
Engineers with the University of Cincinnati have created a tiny portable lab that plugs into your phone, connecting it automatically to a doctor's office through a custom app UC developed. The lab the size of a credit card can diagnose infectious diseases such as coronavirus, malaria, HIV or Lyme disease or countless other health conditions like depression and anxiety.
Targeting the cancer microenvironment
- Details
- Category: Research
The recognition of bacterial infections or foreign substances is mediated and controlled by the human immune system. This innate and adaptive immune system comprises the most important metabolic and cellulare processes to fight against infections and other diseases. Paradoxically, this immune system is also involved in the development of systemic diseases and cancer. Therefore it is of utmost importance to
More Pharma News ...
- Two million Americans lost health coverage/access in Trump's first year
- If cancer were easy, every cell would do it
- Poliovirus therapy shows potential as cancer vaccine in lab studies
- Research offers promise for treating schizophrenia
- Human Body-on-Chip platform enables in vitro prediction of drug behaviors in humans
- A single number helps Stanford data scientists find most dangerous cancer cells
- Inhibition of p38 reduces the growth of lung tumors